期刊文献+

甲状腺髓样癌的临床病理分析 被引量:3

下载PDF
导出
摘要 目的探讨甲状腺髓样癌的形态特征、免疫表型及鉴别诊断。方法对5例经病理诊断为甲状腺髓样癌患者的临床资料、大体及光镜下形态特点及免疫组化结果进行回顾性分析和研究。结果患者以颈部肿物就诊,大体表现为边界清楚的孤立结节,2例有假包膜,癌组织主要由多角形细胞及梭形细胞构成,异型性不一,有多种组织学结构,以巢状和束状为主,少数形成滤泡。3例间质未见淀粉样物,免疫组化降钙素阳性,嗜铬素A、神经元特异性烯醇化酶及突触素阳性程度不一。甲状腺球蛋白1例阳性。结论甲状腺髓样癌形态多样,尤其需要与腺瘤、低分化滤泡癌、未分化癌等鉴别。主要依据形态特点,结合免疫组化等综合判断。 Objective To investigate the pathologicalmorphological and immunohistochemical features and differential diagnosis of medullary thyroid carcinoma (MTC). Methods 5 cases of MTC were confirmed by pathology. The tumors were retrospectively analyzed with clinical data, gross and light microscopy observation and immunohistochemistry. Results The cervial mass was the initial syndrom in the patients.Most tumors were solitary nodule with clear boderline,two of them with disguised capsule. The tumors were composed of spindle and polygonal cells,arranged in various patterns,such as nest-like,fascicular, follicular. There was not amyloid in the stroma of three cases of tumors. The immunohistochemical results showed calcitonin (CT) was positive in all cases,but chromogranin A (CgA), neuron-specific enolase (NSE), synaptophysin (Syn) was positive variously. Thyrogtobulin (TG) was present in one tumor. Conclusion MTC has multiple morphologic features. It was ofen misdiagnosed with adenoma, poor different follicular carcinoma, anaplastic carcinoma. Its diagnosis depends on its histopathology and immunohistochemistry character.
作者 侯兴华 叶新
出处 《当代医学》 2014年第16期7-8,共2页 Contemporary Medicine
关键词 甲状腺肿瘤 甲状腺髓样癌 临床病理学 免疫组化 Thyroid neoplasms Medullary thyroid carcinoma Clinicopathology lmmunohistochemistry
  • 相关文献

参考文献7

二级参考文献34

  • 1滕晓东,王丽君,姚洪田,李君,丁伟,严丽萍.细胞角蛋白19、galectin-3、HBME-1在甲状腺病变上的表达及鉴别诊断意义[J].中华病理学杂志,2004,33(3):212-216. 被引量:33
  • 2关海霞,单忠艳,米小轶,王恩华,滕卫平.普遍食盐碘化前后甲状腺癌发病变化的11年病理资料分析[J].中国医科大学学报,2006,35(3):284-285. 被引量:106
  • 3单忠艳,关海霞.甲状腺癌相关研究进展[J].中国实用内科杂志,2007,27(1):33-36. 被引量:24
  • 4Nix P,Nicolaides A,Coatesworth AP.Thyroid cancer review:presentation and investigation of thyroid cancer.Int J Clin Pract,2005,59:1340-1344.
  • 5Leenhardt L,Bernier MO,Boin-Pineau MH,et al.Advances in diagnostic practices affect thyroid cancer incidence in France.Eur J Endocrinol,2004,150:133-139.
  • 6Zhang HY,Meng X,Du ZX,et al.Significance of survivin,caspase-3,and VEGF expression in thyroid carcinoma.Clin Exp Med,2009,9:207-213.
  • 7Brownlie B,Mercer P,Turner J,et al.Thyroid malignancies:a New Zealand South Island thyroid clinic experience 1995-2006.NZ Med J,2008,121:36-45.
  • 8Al-Zaher N,Al-Salam S,El Teraifi H.Thyroid carcinoma in the United Arab Emirates:perspectives and experience of a tertiary care hospital.Hematol Oncol Stem Cell Ther,2008,1:14-21.
  • 9Bukhari U,Sadiq S,Memon J,et al.Thyroid carcinoma in Pakistan:a retrospective review of 998 cases from an academic referral center.Hematol Oncol Stem Cell Ther,2009,2:345-348.
  • 10Sobrinho-Simoes M,Sambade C,Fonseca E,et al.Poorly differentiated carcinomas of the thyroid gland:a review of the clinicopathologic features of a series of 28 cases of a heterogeneous,clinically aggressive group of thyroid tumors.Int J Surg Pathol,2002,10(2):123-131.

共引文献49

同被引文献12

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部